ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2015

Schedule of Assumptions used in calculating fair value of warrants


Dividend yield			0%
Expected volatility			38%
Risk free interest rates			0.642% - 0.745%
Expected life (in years)			2.01 - 2.57

Schedule of fair value liabilities measured on recurring basis

The fair values and the changes in fair values of the warrants accounted for as a derivative liability is reflected below:


Fair value at December 31, 2014	$	2,198,162
Loss on change in fair value		969,106
Fair value at June 30, 2015	$	3,167,268

Schedule of share-based compensation,stock options,activity

Activity under all of the Company’s equity compensation plans during the six months ended June 30, 2015 is summarized below:


	Shares			Weighted - Average Exercise Price
Outstanding at December 31, 2014		10,343,309		$	1.36
Granted		662,500			1.04
Forfeited		(653,500	)		1.43
Outstanding at June 30, 2015		10,352,309		$	1.34

Schedule of share-based payment award stock options valuation assumptions

The estimated grant date fair values of options granted during the six months ended June 30, 2015 were calculated using the Black-Scholes valuation model, based on the following assumptions:


Dividend yield			0%
Expected volatility			46.7% to 48.8%
Risk free interest rates			1.48% to 1.75%
Expected lives (in years)			6.0

Schedule of employee service share-based compensation, allocation of recognized period costs

The Company records share-based compensation expense on a straight-line basis over the related vesting period. For the periods indicated below, share-based compensation expense, which includes the expense associated with the modification of option terms discussed above, related to options was:


Three Months Ended June 30,
2015		2014
	$774,417		$184,162


Six Months Ended June 30,
2015		2014
	$1,135,042		$363,908

Schedule of stockholders' equity note warrants or rights

Warrants have generally been issued for terms of up to five years. Common stock warrant activity for the six months ended June 30, 2015 was as follows:


	Shares			Weighted - Average Exercise Price
Outstanding at December 31, 2014		20,759,136		$	0.91
Issued		35,000			1.00
Terminated		(25,444	)		8.00
Outstanding at June 30, 2015		20,768,692			0.90

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details